European Journal of Cancer Care最新文献

{"title":"Correction to “Effect of Postoperative Medium-Chain Triglyceride Diet Management in Lung Cancer Patients: A Randomized Controlled Trial”","authors":"","doi":"10.1155/ecc/9827024","DOIUrl":"https://doi.org/10.1155/ecc/9827024","url":null,"abstract":"<p>X. Jia, Z. Liang, D. Cao, and L. Wang, “Effect of Postoperative Medium-Chain Triglyceride Diet Management in Lung Cancer Patients: A Randomized Controlled Trial,” <i>European Journal of Cancer Care</i>, 2025, 1145553, https://doi.org/10.1155/ecc/1145553.</p><p>In the Funding Information section of the published article, the funding information was inadvertently omitted. The correct funding information is as follows: This study was supported by the 2022 Zhejiang Provincial Medical and Health Science and Technology Program (Grant No. 2022KY1102).</p><p>The online version of this article has been corrected accordingly.</p><p>We apologize for this error.</p>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2026 1","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ecc/9827024","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149146552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2026 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148096186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2026 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148096520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2026 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148096519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2026 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148088499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2026 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148087872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2026 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148083995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Oncologist’s Representations of Anticancer Treatments for Patients With Advanced-Stage Cancer: New Perspectives From the COVID-19 Crisis","authors":"Chloé Calvez,&nbsp;Francesca Mininel,&nbsp;Sandrine de Montgolfier,&nbsp;Anthony Gonçalves,&nbsp;Ulrick Leleu,&nbsp;Philippe Rochigneux,&nbsp;Aurélien Proux,&nbsp;Léa Restivo","doi":"10.1155/ecc/7478375","DOIUrl":"10.1155/ecc/7478375","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>In the context of the COVID-19 pandemic, scientific societies of oncology issued guidelines to limit the spread of the virus, in particular by limiting the prescription of cancer treatments with palliative intent. This qualitative study adopts a psychosocial perspective to explore how oncologists experienced these guidelines, and what this reveals about their representations and practices concerning end-of-life treatments.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Conducted in a comprehensive cancer center, the study is based on a mixed-method strategy involving 10 semistructured interviews with oncologists and observation of 13 consultations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The oncologists stated that they were complying with the guidelines, which was perceived as an external argument of authority that made it easier to announce the cessation of treatment. The analysis highlights the sacralization of chemotherapy, a shared feeling of guilt at the idea of stopping cancer treatments, and a representation of palliative care as the moment when there is “nothing more to be done.”</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>The fact that the oncologists reported that previous practices had been reinstated once the health crisis had passed reveals the psychosocial logics at work in their decision-making and communication practices. This study recommends the creation of workshops to raise awareness of the psychosocial factors that influence chemotherapy prescriptions in the advanced stages of the disease.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2026 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ecc/7478375","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147683305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exercise-Based Interventions for Metabolic and Immune Modulation in Prostate Cancer: A Systematic Review and Meta-Analysis of RCTs","authors":"Almudena Martínez-Sánchez,&nbsp;Narcis Gusi,&nbsp;Francisco Javier Dominguez-Muñoz,&nbsp;Juan Luis Leon-Llamas,&nbsp;Santos Villafaina","doi":"10.1155/ecc/6684341","DOIUrl":"10.1155/ecc/6684341","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Purpose</h3>\u0000 \u0000 <p>Prostate cancer is the most common malignancy in men and often leads to treatment-related morbidity, including metabolic alterations and chronic low-grade inflammation. Exercise has been proposed as a supportive strategy to mitigate treatment-related adverse effects. This study systematically reviews the impact of exercise on metabolic-, inflammatory-, hormonal- and tumour-related biomarkers in men with prostate cancer. A meta-analysis explored potential effects according to exercise type.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This systematic review followed PRISMA guidelines and included studies from PubMed, Scopus and Web of Science. Eligible studies involved prostate cancer patients, an exercise intervention and reported outcomes on metabolic, immune or tumour markers. Only randomised controlled trials with a control group were included. Twenty-five articles fulfilled the inclusion criteria. The methodological quality of the studies was assessed using the Cochrane Collaboration’s tool.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 1,093 male participants were included across trials involving resistance, aerobic, combined exercise or yoga interventions. The meta-analysis showed a significant reduction in insulin levels within the combined exercise subgroup (<i>p</i> = 0.03). C-reactive protein was also significantly reduced in pooled analyses (<i>p</i> = 0.001). No consistent significant effects were observed for testosterone, glucose, IL-6 or prostate-specific antigen.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Exercise may induce modest changes in selected systemic biomarkers, particularly CRP, in men with prostate cancer undergoing treatment. However, effects were heterogeneous and generally small, and current evidence does not demonstrate consistent tumour-related modification. Exercise remains an important supportive strategy to enhance physiological resilience, but larger, high-quality trials are required to clarify clinical relevance.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2026 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ecc/6684341","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147684155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Modified Delphi Study on Oral Mucositis/Stomatitis Prevention and Management in Patients Receiving Datopotamab Deruxtecan","authors":"Paolo Bossi,&nbsp;Akin Atmaca,&nbsp;Thomas Bachelot,&nbsp;Rupert Bartsch,&nbsp;Giampaolo Bianchini,&nbsp;Quincy Chu,&nbsp;Robin Cornelissen,&nbsp;Enriqueta Felip,&nbsp;Nicolas Girard,&nbsp;Francesco Passiglia,&nbsp;Sonia Pernas,&nbsp;Melissa Phillips,&nbsp;David Planchard,&nbsp;Claudio Zamagni,&nbsp;Jo Clark,&nbsp;Cecile Matthews,&nbsp;Lutz Goerke,&nbsp;Barbara Pistilli","doi":"10.1155/ecc/6518713","DOIUrl":"https://doi.org/10.1155/ecc/6518713","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Oral mucositis/stomatitis is a common adverse event during cancer treatment that can disrupt oral functioning and adherence to treatment. Datopotamab deruxtecan (Dato-DXd), a TROP2-directed antibody-drug conjugate, has shown promise in treating solid tumors. It has been associated with oral mucositis/stomatitis in clinical trials for breast and lung cancer (TROPION program). Currently, there is a lack of formalized guidelines for managing Dato-DXd-associated oral mucositis/stomatitis. The present study employed a modified Delphi approach to establish expert consensus on preventing, diagnosing, monitoring, and treating oral mucositis/stomatitis secondary to Dato-DXd and to improve patient care and clinical outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>A four-stage modified Delphi study engaging 15 oncology experts from Europe and Canada was used to establish consensus on managing Dato-DXd-induced oral mucositis/stomatitis in lung and breast cancer patients. Experts were selected based on their roles as investigators in Dato-DXd clinical trials, including but not limited to TROPION-PanTumor01, TROPION-Lung01, TROPION-Lung05, and TROPION-Breast01, and their experience managing cancer treatment–associated oral mucositis/stomatitis. The Delphi process included an initial meeting, two anonymized surveys, an in-person consensus meeting, and virtual one-to-one sessions for absentees.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Expert consensus was reached on recommendations for managing Dato-DXd-associated oral mucositis/stomatitis, and experts highlighted the importance of establishing guidance to improve patient quality of life and clinical outcomes. Key recommendations included prophylactic dexamethasone mouthwash, patient education, and behavioral changes. Early detection through self-checks and monitoring was emphasized, and recommended treatment strategies were tailored to oral mucositis/stomatitis severity. Treatment recommendations included dose modifications and discontinuation for severe cases.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This study offers expert guidance on managing Dato-DXd-associated oral mucositis/stomatitis, filling a crucial gap in patient care. Ongoing efforts to generate Dato-DXd-specific data will facilitate the creation of standardized, evidence-based protocols to improve patient safety and treatment outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2026 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ecc/6518713","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147585151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}